News | November 28, 2018

Cell Processing, Gene Therapy And Pharma 4.0 To Be Featured At Interphex 2019

Stem Cell Therapy_Flickr.jpg

International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, announces INNOPHEX will debut at INTERPHEX 2019. In collaboration with IPS-Integrated Project Services, LLC (IPS), a leading provider of Engineering, Procurement, Construction Management and Validation (EPCMV) services, INNOPHEX will feature dedicated exhibits, technical conference and networking opportunities focused on cell processing, gene therapy and Pharma 4.0 technologies, including robotics, 3D printing, augmented reality and virtual reality (AR/VR), Internet of Things (IoT) and the management of information and integrity of data. The collaboration aligns with the goals of both organizations to offer access to the very latest intelligence, cutting-edge technologies and advancements in industry innovation. INTERPHEX and INNOPHEX take place April 2-4, 2019 at the Javits Center, New York, NY.

“We are delighted to collaborate with IPS and together we present, INNOPHEX,” said Michael Mandl, Group Vice President, INTERPHEX. “This event is focused on innovation and IPS the right blend of knowledge and technical expertise to enhance INNOPHEX. With the strength of the North American gene therapy market and the emergence of Pharm 4.0, INNOPHEX offers access to knowledge and solutions to reduce operational costs, increase flexibility and improve processes and productivity in new and innovative ways. We believe adding INNOPHEX to the show floor further strengthens the value proposition of INTERPHEX. As a premier industry event, we continually lead the way in showcasing advancements in pharma, bio and device development and manufacturing solutions to develop and manufacture quality product.”

“Technology continues to transform the industry. But many do not have a clear strategy in place to operationalize these methodologies and technologies. Understanding the needs and wants of the industry has been critical to our success for forty years,” said Kate Scott, Event Director, INTERPHEX. “We are certain that both exhibitors and key decision makers will benefit on how industry leaders are leveraging innovative technology as strategic business and operational assets.”

“We are honored to collaborate on INNOPHEX, designed to bring emphasis to the many innovative manufacturers and equipment suppliers serving the cell and gene therapy industry,” said Tom Piombino, Vice President, IPS. “INNOPHEX provides an exhibition opportunity for companies with a targeted technology portfolio to exhibit at one of the best biopharma technology shows in the world. Growing and sharing knowledge of advancements in our industry is part of our long-standing commitment to our customers, colleagues and employees and serves as the guiding principle behind INNOPHEX and our long established IPS Technologies Tours. With INTERPHEX’s global reach and key decision-making attendees, we believe INNOPHEX will deliver awareness and knowledge sharing that might be critical in getting the next cure to market.”

INTERPHEX and INNOPHEX offer the opportunity to network with leading suppliers and industry professionals, see the latest advancements in technology and equipment and face to face discussions with subject matter experts. One Technical Conference and Exhibit Hall Badge is required to attend INTERPHEX and INNOPHEX. Take advantage of the early bird discount, Register today.

Need to exhibit? Located within INTERPHEX 2019, INNOPHEX offers an opportunity to meet, network and share expertise in a dedicated space featuring exhibitors and a no-cost technical conference program specific to cell processing, gene therapy and Pharma 4.0. Companies interested in exhibiting should contact Todd Sheahan at tsheahan@reedexpo.com or 203.840.5397.

About IPS
IPS is a global leader in developing innovative business solutions for the biotechnology and pharmaceutical industries. Through operational expertise and industry-leading knowledge, skill and passion, IPS provides consulting, architecture, engineering, construction management and compliance services that allow clients to create and manufacture life impacting products around the world. Headquartered in Blue Bell, PA, USA, IPS is one of the fastest-growing companies servicing the life sciences industry with over 1,100 professionals in the US, Canada, Brazil, UK, Ireland, Switzerland, Singapore, China and India. For more information, visit www.ipsdb.com.

About INTERPHEX
For forty years, INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can “Experience Science through Commercialization”. Sponsored by the Parenteral Drug Association

(PDA), the event is based in New York and brings over 12,000 global industry professionals and 625+ industry leading suppliers together to “Learn it, Experience it, Procure it” through a unique combination of exhibits, demonstrations, partnering opportunities, networking and no cost technical conference to leverage quality, efficiency and cost effectiveness in today’s ever-changing global market. INTERPHEX offers annual domestic and international industry events and educational opportunities around the world. INTERPHEX and INNOPHEX together, offer the very latest intelligence, cutting-edge technologies and state-of-the-art innovation throughout the product development life cycle. For more information, visit www.INTERPHEX.com.

SOURCE: IPS-Integrated Project Services, LLC